A strategy for the catalytic, asymmetric alkylation of silyl enol ethers and silyl ketene acetals via chiral nucleophilic catalysis is presented. Peptide-based catalysts containing a nucleophilic residue are predicted to both activate primary alkyl electrophiles toward attack by the silyl enol nucleophiles and provide a chiral environment (by way of the peptide's secondary structure) to induce enantioselectivity in the alkylation event. Specifically, i-butylhistidine is anticipated to be an effective nucleophilic amino acid upon which to build such peptide catalysts. Strategies for optimizing both reactivity and selectivity in the alkylation process are discussed, including catalyst design, the possible benefit of additives, slow addition of reaction components, and the judicious choice of substrates. Development of this method to encompass the use of other nucleophiles including substituted allylstannanes and silanes is proposed. Additionally, the use of alternative electrophiles such as oxygen and halogen sources is discussed.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32GM075585-01
Application #
6998078
Study Section
Special Emphasis Panel (ZRG1-F04A (20))
Program Officer
Marino, Pamela
Project Start
2005-08-01
Project End
2007-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
1
Fiscal Year
2005
Total Cost
$42,068
Indirect Cost
Name
Boston College
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
045896339
City
Chestnut Hill
State
MA
Country
United States
Zip Code
02467